Serum NfL is useful biomarker in pregnancy, say researchers

New data presented in the late-breaking news session of MSVirtual2020 have highlighted the potential clinical value of monitoring serum levels of neurofilament light chain (sNfL) during pregnancy.

Dr Özgür Yaldizli from University Hospital Basel, Switzerland, noted that pregnancy in multiple sclerosis (MS) is typically associated with reduced disease activity (especially in the third trimester), followed by an increase in relapse frequency postpartum.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.